← Leaderboards
Won Jin Ho
Case Western Reserve University
$2,204,849
Attributed
$3,026,131
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,026,131 · 6
By mechanism
R01$1,335,826 · 1
S10$499,199 · 1
R21$421,042 · 1
U19$343,931 · 1
R41$306,739 · 1
F32$119,394 · 1
Top collaborators
- Mark Yarchoan2 shared
- Deepa Sengupta1 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Liem Duy Nguyen$2,802,112
- Jian-Ping Jin$16,836,560
- Christopher Hernandez$66,102
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsResponseCytometryImmuneT-LymphocyteImmune ResponseImageTumorGlobal HealthMediatingPathway InteractionsTumor-Immune System InteractionsTissuesUnited StatesFutureImmune SystemPhenotypePreventMucous MembraneOperative Surgical ProceduresMolecularMyelogenousCell TypeMalignant Neoplasm Of Liver
Grant awards (9)
Neoadjuvant Immunotherapy Platform Study Reveals Mechanisms of Response in Hepatocellular Carcinoma (HCC)$673,789
R01 · FY2025 · CA
Inhibitors of ENPP1 for the treatment of hepatocellular carcinoma$306,739
R41 · FY2025 · CA
Imaging Mass Cytometry Core$206,670
U19 · FY2025 · AI · contact PI
Neoadjuvant Immunotherapy Platform Study Reveals Mechanisms of Response in Hepatocellular Carcinoma (HCC)$662,037
R01 · FY2024 · CA
Mass Cytometer CyTOF XT for Single-Cell Biology$499,199
S10 · FY2024 · OD · contact PI
Imaging Mass Cytometry Core$137,261
U19 · FY2024 · AI · contact PI
Immunophenotype Integration for Monitoring T Cell Dynamics in Pancreatic Cancers$421,042
R21 · FY2021 · CA · contact PI
Exploring 15-hydroxyprostaglandin dehydrogenase as a molecular target for treating inflammatory bowel diseases$61,601
F32 · FY2016 · DK · contact PI
Exploring 15-hydroxyprostaglandin dehydrogenase as a molecular target for treating inflammatory bowel diseases$57,793
F32 · FY2015 · DK · contact PI